Pfizer Inc logo

PFE - Pfizer Inc News Story

$40.19 0.1  0.2%

Last Trade - 8:26pm

Sector
Healthcare
Size
Large Cap
Market Cap £158.85bn
Enterprise Value £177.44bn
Revenue £32.83bn
Position in Universe 38th / 6846

Italy reported four clot deaths after AstraZeneca shots, data shows

Thu 15th April, 2021 3:57pm
ROME, April 15 (Reuters) - Four people died in Italy from
rare blood clots after they received the AstraZeneca  AZN.L 
COVID-19 vaccine, a report from the AIFA national pharmaceutical
agency said on Thursday.
    The AIFA report said various side-effects were seen
following 0.5% of the 9.07 million doses administered between
Dec. 27 and March 26, with all three vaccines so far used, by
manufacturers Pfizer  PFE.N , AstraZeneca and Moderna  MRNA.O ,
reported to have triggered unwelcome reactions. 
    Severe side-effects were registered in 0.04% of cases. 
    Mild side-effects have been reported after use of all three
vaccines, the AIFA report said, adding most involved flu-like
symptoms, pain in the injection site and tiredness.
    Like many European countries, Italy briefly halted
AstraZeneca inoculations last month when blood clot concerns
surfaced. It has since resumed them for those aged 60 and above
after EU regulators said the benefits outweighed the risks.
    AIFA said there had been 11 cases in Italy of people
developing one of two types of blood clots following their
AstraZeneca shot - cerebral venous sinus thrombosis (CVST) and
thrombosis involving multiple blood vessels
    Four of the 11 died, it said.
    AstraZeneca has said it is "working to understand individual
cases and "possible mechanisms that could explain these
extremely rare events".

 (Reporting by Angelo Amante, editing by Crispian Balmer and
Nick Macfie)
 ((Angelo.Amante@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.